FDA Approved: MERCAPTOPURINE — Supplemental Application (Nova Laboratories, Ltd)

View source ↗

Summary

FDA approved a supplemental application for Mercaptopurine (Purixan) submitted by Nova Laboratories, Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Purixan (Mercaptopurine)

Snippet

SUPPL AP for MERCAPTOPURINE (MERCAPTOPURINE)